- Home
- Publications
- Publication Search
- Publication Details
Title
NAD Metabolism in Cancer Therapeutics
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-12
DOI
10.3389/fonc.2018.00622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAD metabolism: Implications in aging and longevity
- (2018) Keisuke Yaku et al. AGEING RESEARCH REVIEWS
- Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance
- (2018) Maryam Gulshan et al. AGING CELL
- Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma
- (2018) Yasutaka Yamada et al. CANCER SCIENCE
- Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells
- (2018) Zahra Hesari et al. GENE
- Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma
- (2018) Valentina Audrito et al. Oncotarget
- CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+Pools
- (2018) Jeffrey P. Chmielewski et al. MOLECULAR CANCER RESEARCH
- Genotype-targeted local therapy of glioma
- (2018) Ganesh M. Shankar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis
- (2018) J. Patrick Murphy et al. Cell Reports
- NAD metabolism fuels human and mouse intestinal inflammation
- (2017) Romana R Gerner et al. GUT
- Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
- (2017) Genshi Zhao et al. MOLECULAR CANCER THERAPEUTICS
- NAD + in Aging: Molecular Mechanisms and Translational Implications
- (2017) Evandro F. Fang et al. TRENDS IN MOLECULAR MEDICINE
- Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
- (2017) Jair Machado Espindola-Netto et al. Oncotarget
- NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
- (2017) Antonio Lucena-Cacace et al. Oncotarget
- Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy
- (2017) Jonathan Cole et al. Oncotarget
- Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
- (2017) Yifan Sun et al. Oncotarget
- Serine-Dependent Sphingolipid Synthesis Is a Metabolic Liability of Aneuploid Cells
- (2017) Sunyoung Hwang et al. Cell Reports
- Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
- (2016) Xiumei Huang et al. CANCER CELL
- Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
- (2016) Huai-Qiang Ju et al. CANCER LETTERS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle
- (2016) David W. Frederick et al. Cell Metabolism
- CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
- (2016) Juliana Camacho-Pereira et al. Cell Metabolism
- Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
- (2016) O. Abu Aboud et al. MOLECULAR CANCER THERAPEUTICS
- Oncogenic regulation of tumor metabolic reprogramming
- (2016) Míriam Tarrado-Castellarnau et al. Oncotarget
- NAMPT-Mediated NAD + Biosynthesis Is Essential for Vision In Mice
- (2016) Jonathan B. Lin et al. Cell Reports
- Nicotinamide Mononucleotide Adenylyl Transferase 2: A Promising Diagnostic and Therapeutic Target for Colorectal Cancer
- (2016) Chunhui Cui et al. Biomed Research International
- Immunotherapies targeting CD38 in Multiple Myeloma
- (2016) Djordje Atanackovic et al. OncoImmunology
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism
- (2015) Jianrong Lu et al. CANCER LETTERS
- SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
- (2015) Myeong Jin Yoon et al. Cell Metabolism
- The Warburg effect: Evolving interpretations of an established concept
- (2015) Xiaozhuo Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells
- (2015) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Secretion of One Adipokine Nampt/Visfatin Suppresses the Inflammatory Stress-Induced NF-κB Activity and Affects Nampt-Dependent Cell Viability in Huh-7 Cells
- (2015) Yi-Ching Lin et al. MEDIATORS OF INFLAMMATION
- High glucose promotes gastric cancer chemoresistance in vivo and in vitro
- (2015) WEI ZHAO et al. Molecular Medicine Reports
- Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer
- (2015) YANYAN ZHU et al. ONCOLOGY REPORTS
- Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
- (2015) Ambra A. Grolla et al. Pigment Cell & Melanoma Research
- Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
- (2015) Nadia Sawicka-Gutaj et al. TUMOR BIOLOGY
- Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors
- (2015) Sara Duarte-Pereira et al. Oncotarget
- Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
- (2015) Katarzyna Neubauer et al. Biomed Research International
- Supplementation of Nicotinic Acid with NAMPT Inhibitors Results in Loss of In Vivo Efficacy in NAPRT1-Deficient Tumor Models
- (2015) Thomas O'Brien et al. NEOPLASIA
- NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes
- (2014) Drew J. Adams et al. ACS Chemical Biology
- Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
- (2014) Valentina Audrito et al. BLOOD
- Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
- (2014) Krishna S. Tummala et al. CANCER CELL
- BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer
- (2014) Da Li et al. CELL CYCLE
- The NAD+synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target
- (2014) Lu-Zhe Pan et al. CELL CYCLE
- On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
- (2014) I. Gehrke et al. CLINICAL CANCER RESEARCH
- Depletion of the Central Metabolite NAD Leads to Oncosis-mediated Cell Death
- (2014) Christopher Del Nagro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity
- (2014) Debora Soncini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuronal NAMPT is Released after Cerebral Ischemia and Protects against White Matter Injury
- (2014) Zheng Jing et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Serine and glycine metabolism in cancer
- (2014) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mechanical Stress Induces PBEF/NAMPTExpression via Epigenetic Regulation bymiR-374αandmiR-568in Human Lung Endothelium
- (2013) Djanybek M Adyshev et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
- (2013) Xiaozhang Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin
- (2013) P Kusumanchi et al. CANCER GENE THERAPY
- Next-Generation NAMPT Inhibitors Identified by Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens
- (2013) Christina J. Matheny et al. CHEMISTRY & BIOLOGY
- Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors
- (2013) D. S. Shames et al. CLINICAL CANCER RESEARCH
- CD38 and CD157: A long journey from activation markers to multifunctional molecules
- (2013) Valeria Quarona et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2
- (2013) HONGQI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors
- (2013) Xiaozhang Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression and Regulation of Nampt in Human Islets
- (2013) Karen Kover et al. PLoS One
- Nicotinamide Phosphoribosyl Transferase (Nampt) Is a Target of MicroRNA-26b in Colorectal Cancer Cells
- (2013) Chenpeng Zhang et al. PLoS One
- Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
- (2012) Ilirjana Bajrami et al. EMBO Molecular Medicine
- Regulation of Poly(ADP-ribose) Polymerase-1-dependent Gene Expression through Promoter-directed Recruitment of a Nuclear NAD+Synthase
- (2012) Tong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, in Human Cancer Cells
- (2012) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resurgence of Serine: An Often Neglected but Indispensable Amino Acid
- (2012) Satish C. Kalhan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
- (2012) Simona Morone et al. PLoS One
- Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
- (2011) UFFE HØGH OLESEN et al. APMIS
- NMNAT Expression and its Relation to NAD Metabolism
- (2011) H. N. Jayaram et al. CURRENT MEDICINAL CHEMISTRY
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
- (2011) Jason W Locasale et al. NATURE GENETICS
- Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil
- (2011) Xiang-Ming Che ONCOLOGY REPORTS
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
- (2011) D. A. Chan et al. Science Translational Medicine
- Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma
- (2010) H. Kato et al. CLINICAL CANCER RESEARCH
- Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma
- (2010) Erika Ortolan et al. JNCI-Journal of the National Cancer Institute
- Visfatin stimulates proliferation of MCF-7 human breast cancer cells
- (2010) Jae Geun Kim et al. MOLECULES AND CELLS
- NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
- (2010) B Wang et al. ONCOGENE
- IDH mutations in glioma and acute myeloid leukemia
- (2010) Lenny Dang et al. TRENDS IN MOLECULAR MEDICINE
- Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes
- (2009) A. Garten et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
- (2009) Anne von Heideman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Enzymes in the NAD+Salvage Pathway Regulate SIRT1 Activity at Target Gene Promoters
- (2009) Tong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer
- (2009) Takako Eguchi Nakajima et al. JOURNAL OF GASTROENTEROLOGY
- The Small Molecule GMX1778 Is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors
- (2009) M. Watson et al. MOLECULAR AND CELLULAR BIOLOGY
- A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis
- (2009) Snehal T. Patel et al. PEPTIDES
- Anticancer agent CHS-828 inhibits cellular synthesis of NAD
- (2008) Uffe Høgh Olesen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis
- (2008) Yun-Hee Bae et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More